New Mayo Clinic, Cancer Genetics Joint Venture to Discover, Market Biomarkers for Cancer
OncoSpire Genomics will seek to discover and commercialize biomarkers for multiple cancer types.
Read MorePosted by Judy O'Rourke | May 22, 2013 | Cancer, Molecular Diagnostics, Research |
OncoSpire Genomics will seek to discover and commercialize biomarkers for multiple cancer types.
Read MorePosted by Judy O'Rourke | May 15, 2013 | Miscellaneous |
Since Joe Miles, MT(ASCP), MHS, first spoke with CLP about ACOs in 2011, 260 Medicare ACOs, providing coverage for an estimated four million Medicare beneficiaries, have been established. CLP circles back with Miles for an update.
Read MorePosted by Judy O'Rourke | May 10, 2013 | Molecular Diagnostics |
A coalition representing more than 120,000 medical and laboratory professionals and institutions that perform the vast majority of clinical molecular pathology testing in the United States have released a joint statement regarding new Medicare prices
Read MorePosted by Judy O'Rourke | May 8, 2013 | Cardiovascular, Molecular Diagnostics |
The newly validated tests cover the major causes of cardiomyopathies, arrhythmia disorders, and other genetically transmitted diseases that affect the heart and vasculature.
Read MorePosted by Judy O'Rourke | May 3, 2013 | Accessories, Anatomic Pathology, Information Technology, Lab Automation |
The array of products ranges from mouse monoclonal antibodies to pathology information systems.
Read More